1. Home
  2. BMRN vs CART Comparison

BMRN vs CART Comparison

Compare BMRN & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.19

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Logo Maplebear Inc.

CART

Maplebear Inc.

HOLD

Current Price

$44.03

Market Cap

12.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
CART
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
12.2B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
BMRN
CART
Price
$53.19
$44.03
Analyst Decision
Buy
Buy
Analyst Count
19
24
Target Price
$88.42
$53.13
AVG Volume (30 Days)
3.0M
6.5M
Earning Date
10-27-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
59.53
18.25
EPS
2.68
1.81
Revenue
$3,094,001,000.00
$3,633,000,000.00
Revenue This Year
$13.39
$12.40
Revenue Next Year
$7.57
$9.35
P/E Ratio
$19.92
$24.35
Revenue Growth
12.39
10.16
52 Week Low
$50.76
$34.78
52 Week High
$73.51
$53.50

Technical Indicators

Market Signals
Indicator
BMRN
CART
Relative Strength Index (RSI) 46.19 67.40
Support Level $53.03 $41.07
Resistance Level $54.66 $42.86
Average True Range (ATR) 1.45 1.22
MACD -0.11 0.33
Stochastic Oscillator 31.61 98.51

Price Performance

Historical Comparison
BMRN
CART

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About CART Maplebear Inc.

Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.

Share on Social Networks: